Barry Clare

Clarat Partners LLP (Clarat) is a specialist UK investment firm which was established by Barry Clare and David Karat in 2003 to facilitate private equity investments in healthcare assets. Based in London, Clarat aims to share their expertise, participate in sector and transaction evaluations and co-invest in attractive transactions in the healthcare, beauty, personal care and well-being sectors and to work with private equity firms and other investors who wish to become involved in these sectors or to increase their exposure to them.

Healthcare Brands International (HBI) is a new company, established in the UK in October 2006, and participating primarily in the growing market of OTC Medicines. The company is committed to acquiring, developing and investing in differentiated healthcare products. In short it will translate innovative science into meaningful consumer brands. Funded with over £100 million of venture capital from leading international venture capital investors, the company is a team of experienced OTC blue chip business professionals with an unrivalled network of partners and contacts around the world (with particular strength in Europe). It brings core skills in consumer marketing and brand development and combine with partners providing in-market operational and regulatory expertise. It will focus on innovative products with meaningful and substantiated differentiation that meet a relevant and yet unmet or only partially met consumer need and thereby help grow the overall self-medication market.

Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom.

Floback Ltd. develops and manufactures medical devices for treating and managing lower back problems. It offers PosturePlast, designed to help relieve lower back pain by addressing the root cause of most mechanical back problems, bad posture. The company product PosturePlast is an X-shaped adhesive support for the lower back that contains a flexible strut. Floback was founded by Adam Dallison in 2011 and is headquartered in London, the United Kingdom.

Crescent Diagnostics Ltd. operates as a medical diagnostics company. The firm offers bone quality test, an osteoporosis screening tool that enables clinicians to identify those who are at high risk of suffering a hip fracture. The company was founded by Mark Towler and Ernest Poku in 2004 and is headquartered in London, the United Kingdom.

The Boots Co. Plc owns and operates a chain of pharmaceutical and personal care retail stores. The firm’s stores are consists of local pharmacies, a healthcare-focused community stores; convenience and high-street stores offering pharmacy-led care. The company is headquartered in Nottingham, the United Kingdom.

betapharm Arzneimittel GmbH develops and provides generic drugs. It offers social-medical research, advanced training, consulting, project development as well as information services. The company was founded in 1993 and is headquartered in Augsburg, Germany.

Famy Care Ltd. manufactures and supplies hormonal and reproductive health care products for women. It offers oral and emergency contraceptives, intra uterine devices, tubal ligation rings, progestagen only pills, hormonal tablets, and cancer detection kits. The company was founded by Jyotiprasad Taparia in 1990 and is headquartered in Mumbai, India.